On September 7, 2022 Avid Bioservices, Inc. (NASDAQ:CDMO), a dedicated biologics contract development and manufacturing organization (CDMO) working to improve patient lives by providing high quality development and manufacturing services to biotechnology and pharmaceutical companies, reported that the company will participate in the Morgan Stanley 20th Annual Global Healthcare Conference (Press release, Avid Bioservices, SEP 7, 2022, View Source [SID1234619149]). Nick Green, president and chief executive officer of Avid Bioservices, will be the featured speaker in a fireside chat at the conference, which will take place September 12-14, 2022, in New York City.
Schedule your 30 min Free 1stOncology Demo!
Discover why more than 1,500 members use 1stOncology™ to excel in:
Early/Late Stage Pipeline Development - Target Scouting - Clinical Biomarkers - Indication Selection & Expansion - BD&L Contacts - Conference Reports - Combinatorial Drug Settings - Companion Diagnostics - Drug Repositioning - First-in-class Analysis - Competitive Analysis - Deals & Licensing
Schedule Your 30 min Free Demo!
Details of the company’s participation are as follows:
Morgan Stanley 20th Annual Global Healthcare Conference
Conference Date: September 12-14, 2022
Fireside Chat Time/Date: 12:55 – 1:25 p.m. Eastern on Wednesday, September 14, 2022
Location: Sheraton New York Hotel; webcast available
To listen to the live webcast of the Morgan Stanley fireside chat, or access the archived webcast, please visit: View Source